Drugs / Antivenin Centruroides (scorpion) equine immune F(ab)2
Antivenin Centruroides (scorpion) equine immune F(ab)2
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial · 1 met primary | ||||||
| Phase 2/3 | NCT00685230 | May 2004 → Aug 2005 | scorpion envenomation | Instituto Bioclon S.A. de C.V. | Completed | Met primary |
| Phase 31 trial | ||||||
| Phase 3 | NCT01599923 | May 2005 → Jun 2006 | scorpion envenomation | Instituto Bioclon S.A. de C.V. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Antivenin Centruroides (scorpion) equine immune F(ab')2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01599923 ↗ |
| Modality | Protein / enzyme biologic | “scorpion-specific F(ab')(2) antivenom” PMID 19439743 ↗ May 2009 |
| Route | Intravenous | “intravenous administration of scorpion-specific F(ab')(2) antivenom” PMID 19439743 ↗ May 2009 |